Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Bullock

Showing results (191-200 of 220) with videos related to

Pageof 22
Sort By:
Structure (London, England : 1993)|July 7, 2021
Selection and structural characterization of anti-TREM2 scFvs that reduce levels of shed ectodomainAleksandra Szykowska, Yu Chen, Thomas B Smith, et al.
Journal of Medicinal Chemistry|May 4, 2026
Targeting Activin Receptor-like Kinase 2 Using Heterobifunctional Protein DegradersDaniel T Webb, Katherine L Jones, Natsuko Macabuag, et al.
European Journal of Human Genetics : EJHG|January 22, 2015
Clinical Utility Gene Card for: Fibrodysplasia ossificans progressivaNathalie Bravenboer, Dimitra Micha, James T Triffit, et al.
JBMR Plus|November 27, 2019
Development of Macrocycle Kinase Inhibitors for ALK2 Using Fibrodysplasia Ossificans Progressiva-Derived Endothelial CellsGonzalo Sánchez-Duffhues, Eleanor Williams, Pascal Benderitter, et al.
Plos One|July 23, 2013
Adding diverse noncanonical backbones to rosetta: enabling peptidomimetic designKevin Drew, P Douglas Renfrew, Timothy W Craven, et al.
Journal of Medical Genetics|January 31, 2024
BTB domain mutations perturbing KCTD15 oligomerisation cause a distinctive frontonasal dysplasia syndromeKerry A Miller, David A Cruz Walma, Daniel M Pinkas, et al.
Nature Chemical Biology|August 30, 2016
Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitorsTinghu Zhang, Nicholas Kwiatkowski, Calla M Olson, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiologyAnna Castano, Margaux Silvestre, Carrow I Wells, et al.
Nature Genetics|April 8, 2014
Recurrent activating ACVR1 mutations in diffuse intrinsic pontine gliomaKathryn R Taylor, Alan Mackay, Nathalène Truffaux, et al.
Cancer Cell|March 7, 2020
Mutant ACVR1 Arrests Glial Cell Differentiation to Drive Tumorigenesis in Pediatric GliomasJerome Fortin, Ruxiao Tian, Ida Zarrabi, et al.
Pageof 22

Showing results (191-200 of 220) with videos related to

Sort By:
Pageof 22
Structure (London, England : 1993)|July 7, 2021
Selection and structural characterization of anti-TREM2 scFvs that reduce levels of shed ectodomainAleksandra Szykowska, Yu Chen, Thomas B Smith, et al.
Journal of Medicinal Chemistry|May 4, 2026
Targeting Activin Receptor-like Kinase 2 Using Heterobifunctional Protein DegradersDaniel T Webb, Katherine L Jones, Natsuko Macabuag, et al.
European Journal of Human Genetics : EJHG|January 22, 2015
Clinical Utility Gene Card for: Fibrodysplasia ossificans progressivaNathalie Bravenboer, Dimitra Micha, James T Triffit, et al.
JBMR Plus|November 27, 2019
Development of Macrocycle Kinase Inhibitors for ALK2 Using Fibrodysplasia Ossificans Progressiva-Derived Endothelial CellsGonzalo Sánchez-Duffhues, Eleanor Williams, Pascal Benderitter, et al.
Plos One|July 23, 2013
Adding diverse noncanonical backbones to rosetta: enabling peptidomimetic designKevin Drew, P Douglas Renfrew, Timothy W Craven, et al.
Journal of Medical Genetics|January 31, 2024
BTB domain mutations perturbing KCTD15 oligomerisation cause a distinctive frontonasal dysplasia syndromeKerry A Miller, David A Cruz Walma, Daniel M Pinkas, et al.
Nature Chemical Biology|August 30, 2016
Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitorsTinghu Zhang, Nicholas Kwiatkowski, Calla M Olson, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiologyAnna Castano, Margaux Silvestre, Carrow I Wells, et al.
Nature Genetics|April 8, 2014
Recurrent activating ACVR1 mutations in diffuse intrinsic pontine gliomaKathryn R Taylor, Alan Mackay, Nathalène Truffaux, et al.
Cancer Cell|March 7, 2020
Mutant ACVR1 Arrests Glial Cell Differentiation to Drive Tumorigenesis in Pediatric GliomasJerome Fortin, Ruxiao Tian, Ida Zarrabi, et al.
Pageof 22